ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 194 filers reported holding ACORDA THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $377,000 | -41.0% | 24,224 | -25.5% | 0.01% | -33.3% |
| Q3 2018 | $639,000 | -48.1% | 32,532 | -24.2% | 0.01% | -50.0% |
| Q2 2018 | $1,232,000 | +2.1% | 42,938 | -15.9% | 0.02% | +5.9% |
| Q1 2018 | $1,207,000 | +28.0% | 51,048 | +16.2% | 0.02% | +21.4% |
| Q4 2017 | $943,000 | -74.1% | 43,945 | -71.4% | 0.01% | -73.6% |
| Q3 2017 | $3,636,000 | +120.6% | 153,742 | +83.7% | 0.05% | +130.4% |
| Q2 2017 | $1,648,000 | -39.4% | 83,673 | -35.4% | 0.02% | -34.3% |
| Q1 2017 | $2,718,000 | -8.5% | 129,429 | -18.0% | 0.04% | -7.9% |
| Q4 2016 | $2,969,000 | +67.6% | 157,919 | +86.2% | 0.04% | +65.2% |
| Q3 2016 | $1,771,000 | +0.4% | 84,796 | +22.6% | 0.02% | +9.5% |
| Q2 2016 | $1,764,000 | +134.0% | 69,175 | +142.6% | 0.02% | +162.5% |
| Q1 2016 | $754,000 | -88.6% | 28,514 | -82.4% | 0.01% | -84.9% |
| Q4 2014 | $6,607,000 | +29.5% | 161,650 | +7.3% | 0.05% | +3.9% |
| Q3 2014 | $5,103,000 | +195.3% | 150,609 | +193.8% | 0.05% | +131.8% |
| Q2 2014 | $1,728,000 | – | 51,262 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PFM Health Sciences, LP | 1,526,174 | $1,423,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 250,271 | $233,000 | 0.06% |
| Spark Investment Management LLC | 110,300 | $102,000 | 0.05% |
| SALZHAUER MICHAEL | 30,000 | $28,000 | 0.05% |
| HAP Trading, LLC | 260,800 | $532,000 | 0.04% |
| Point72 Asset Management, L.P. | 1,589,600 | $1,482,000 | 0.01% |
| DLD Asset Management, LP | 208,400 | $196,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 1,893,678 | $1,765,000 | 0.01% |
| EVERENCE CAPITAL MANAGEMENT INC | 65,680 | $61,000 | 0.01% |
| Benin Management CORP | 11,714 | $11,000 | 0.01% |